Nephros (NEPH) Total Current Liabilities (2010 - 2026)

Nephros' Total Current Liabilities history runs 17 years deep, the most recent figure standing at $2.5 million for Q1 2026.

• In Q1 2026, Total Current Liabilities rose 66.47% year-over-year to $2.5 million; the TTM figure through Mar 2026 stood at $2.5 million (up 66.47% YoY), while the FY2025 annual figure was $2.8 million, up 77.14% from the prior year.
• Total Current Liabilities was $2.5 million for Q1 2026 at Nephros, down from $2.8 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $2.8 million in Q4 2025 to a low of $1.1 million in Q3 2024.
• Historically, Total Current Liabilities has averaged $1.8 million across 5 years, with a median of $1.8 million in 2025.
• The sharpest annual moves came in 2023 and 2025: Total Current Liabilities slumped 43.3% in 2023, then surged 133.18% in 2025.
• A 5-year view of Total Current Liabilities shows it stood at $1.4 million in 2022, then jumped by 49.65% to $2.1 million in 2023, then declined by 26.08% to $1.6 million in 2024, then jumped by 77.14% to $2.8 million in 2025, then declined by 8.67% to $2.5 million in 2026.
• The last three Total Current Liabilities figures came in at $2.5 million (Q1 2026), $2.8 million (Q4 2025), and $2.5 million (Q3 2025), per Business Quant data.